Showing results (151-160 of 400) with videos related to
Sort By:
Pageof 40
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1988
Lack of influence of sulglycotide on naproxen bioavailability in healthy volunteersF Berté, F Feletti, M B di Valserra, et al.European Journal of Clinical Pharmacology|January 1, 1988
Lack of effect of a single-dose of sulglicotide on the bioavailability of diclofenacM De Bernardi di Valserra, F Feletti, F Bertè, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Heparin-induced thrombocytopenic potential of GAG and non-GAG-based antithrombotic agentsW P Jeske, A M Jay, S Haas, et al.The Journal of Burn Care & Rehabilitation|February 7, 2001
Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuriesA Kowal-Vern, V McGill, J M Walenga, et al.Thrombosis Research|July 15, 1992
Ex vivo activity of heparin is not predictive of blood loss after neutralization by protamineA Racanelli, J FareedThrombosis Research|November 1, 1992
Neutralization of the antithrombotic effects of heparin and Fraxiparin by protamine sulfateA Racanelli, J FareedThrombosis and Haemostasis|October 1, 1996
Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosisB Kaiser, J FareedSeminars in Thrombosis and Hemostasis|November 5, 1999
In vitro studies on the biochemistry and pharmacology of low molecular weight heparinsW Jeske, J FareedSeminars in Thrombosis and Hemostasis|January 1, 1996
Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosisJ Amiral, J FareedThrombosis and Haemostasis|July 1, 1995
Comparative pharmacology of site directed antithrombin agents. Implication in drug developmentD Callas, J FareedPageof 40